These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19698809)

  • 41. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.
    Al Awaidy S
    Vaccine; 2010 Apr; 28 Suppl 1():A39-41. PubMed ID: 20412995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The National Advisory Group on Immunization (NAGI) of the Republic of South Africa.
    Schoub BD; Ngcobo NJ; Madhi S
    Vaccine; 2010 Apr; 28 Suppl 1():A31-4. PubMed ID: 20412993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding.
    Sinclair S; Hagen NA; Chambers C; Manns B; Simon A; Browman GP
    Health Policy; 2008 May; 86(2-3):381-90. PubMed ID: 18243395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
    Donadel M; Panero MS; Ametewee L; Shefer AM
    Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of decision support technologies for amniocentesis.
    Durand MA; Boivin J; Elwyn G
    Hum Reprod Update; 2008; 14(6):659-68. PubMed ID: 18772266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. National Immunization Commission: strengthening evidence-based decision making in Argentina.
    Stecher D; Gaiano A; Biscayart C; Gentile A; Ayala SG; López E; Bonvehí P; Yedlin P; Janusz C; Vizzotti C
    Vaccine; 2014 Apr; 32(16):1778-80. PubMed ID: 24530935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. National Advisory Groups and their role in immunization policy-making processes in European countries.
    Nohynek H; Wichmann O; D Ancona F;
    Clin Microbiol Infect; 2013 Dec; 19(12):1096-105. PubMed ID: 23957860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
    Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
    Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Searching for diabetes decision aids and related background information.
    Lenz M; Kasper J; Mühlhauser I
    Diabet Med; 2006 Aug; 23(8):912-6. PubMed ID: 16911631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Policy challenges in malaria vaccine introduction.
    Moree M; Ewart S
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):248-52. PubMed ID: 15331844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends.
    Rossi IA; Zuber PL; Dumolard L; Walker DG; Watt J
    Vaccine; 2007 Oct; 25(41):7075-80. PubMed ID: 17825458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of National Immunization Technical Advisory Group on improvement of immunization programmes in the Islamic Republic of Iran.
    Zahraei SM; Marandi A; Sadrizadeh B; Gouya MM; Rezaei P; Vazirian P; Yaghini F
    Vaccine; 2010 Apr; 28 Suppl 1():A35-8. PubMed ID: 20412994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic evaluation of human papillomavirus vaccination in developed countries.
    Brisson M; Van de Velde N; Boily MC
    Public Health Genomics; 2009; 12(5-6):343-51. PubMed ID: 19684446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. National decision-making on adopting new vaccines: a systematic review.
    Burchett HE; Mounier-Jack S; Griffiths UK; Mills AJ
    Health Policy Plan; 2012 May; 27 Suppl 2():ii62-76. PubMed ID: 21733989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of remedial countermeasures using the analytic network process.
    Promentilla MA; Furuichi T; Ishii K; Tanikawa N
    Waste Manag; 2006; 26(12):1410-21. PubMed ID: 16412627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decision-making in priority setting for medicines--a review of empirical studies.
    Vuorenkoski L; Toiviainen H; Hemminki E
    Health Policy; 2008 Apr; 86(1):1-9. PubMed ID: 17950484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
    Tate JE; Rheingans RD; O'Reilly CE; Obonyo B; Burton DC; Tornheim JA; Adazu K; Jaron P; Ochieng B; Kerin T; Calhoun L; Hamel M; Laserson K; Breiman RF; Feikin DR; Mintz ED; Widdowson MA
    J Infect Dis; 2009 Nov; 200 Suppl 1():S76-84. PubMed ID: 19817618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.